Stephen L. Mathias

Stephen L. Mathias

Auto-generated profile, based on publicly available information

Stephen L. Mathias

Chemistry and Chemical Biology, University of New Mexico

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2022 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
KKKeith J Kelleher
Keith J Kelleher
TSTimothy K Sheils
Timothy K Sheils
SMStephen L Mathias
Stephen L Mathias
JYJeremy J Yang
Jeremy J Yang
VMVincent T Metzger
Vincent T Metzger
TOTudor I Oprea
Tudor I Oprea
The Illuminating the Druggable Genome (IDG) project aims to improve our understanding of understudied proteins and our ability to study them in the context of disease biology by perturbing them with small molecules, biologics, or other therapeutic modalities. Two main products from the IDG effort are the Target Central Resource Database (TCRD) (http://juniper.health.unm.edu/tcrd/), which curates and aggregates information, and Pharos (https://pharos.nih.gov/), a web interface for fusers to extract and visualize data from TCRD. Since the 2021 release, TCRD/Pharos has focused on developing visualization and analysis tools that help reveal higher-level patterns in the underlying data. The current iterations of TCRD and Pharos enable users to perform enrichment calculations based on subsets of targets, diseases, or ligands and to create interactive heat maps and UpSet charts of many types of annotations. Using several examples, we show how to address disease biology and drug discovery questions through enrichment calculations and UpSet charts.

1 February 2017 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
SMSubramani Mani
Subramani Mani
DCDaniel Cannon
Daniel Cannon
RORobin K Ohls
Robin K Ohls
TOTudor Oprea
Tudor Oprea
SMStephen Mathias
Stephen Mathias
CBCristian Bologa
Cristian Bologa

11 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ÁHÁdám M. Halász
Ádám M. Halász
SMStephen L. Mathias
Stephen L. Mathias
SDSrinjoy Das
Srinjoy Das
JEJeremy S. Edwards
Jeremy S. Edwards
A bstract: We use machine learning with standardized molecular structure and gene ontology data to predict ligand interactions for a set of human kinases. We realize this by leveraging information from the TCRD / Pharos database, developed and maintained within the Illuminating the Druggable Genome (IDG) project. Pharos collects relevant biochemical and clinically relevant information of a large set of biologically important (human) proteins from publicly available sources, including scientific publications as well as specialized databases. The 635 kinases listed in Pharos are classified into levels reflecting the relative amount and type of accumulated information. Importantly, molecular structure and Gene Ontology annotations are available for the entire set, but only 455 of the kinases have recorded ligand affinity data. We developed a deep neural network-based framework to predict the ligand affinity profile for kinases using generally available information (molecular structure and Gene Ontology annotations) as input. The input data is organized into a 2,770 – dimensional vector with binary entries. The output data are predicted affinity values for interactions between the respective kinase and possible ligands. To address the very large number of possible ligands (58,800) and the sparsity of available binding data, we organized the ligands into 5,275 clusters based on structural similarity measures. Our model framework is trained to predict likely interactions between kinases and these ligand clusters. We aim to identify sets of likely ligand partners associated with high predicted relative affinities for a given kinase. We measure performance by evaluating the efficiency in identifying known ligand partners for documented kinases that were not included in the training data. Our results indicate that our model framework can identify sets of ligands that will contain a significant fraction of the correct (known) ligand partners.